trump medicare glp 1 GLP-1 Access Program May Enable Affordable Access For Some On Trump admin locks in 2027

Efficacy of Glucagon-like Peptide-1 Receptor Agonists in Overweight/Obese and/or T2DM Adolescents: A Meta-Analysis Based on Randomized Controlled Trials

J Nucl Med 1990

Drug repurposing: a promising tool to accelerate the drug discovery process

Pflugers Arch1990 Jan;415(4):479-83

In both patient populations with pre-existing cardiovascular disease, DPP-4 inhibitors are recommended as one possible third-line therapy besides SGLT-2 inhibitors, thiazolidinediones, or insulin, when therapeutic goals are not met with the previous dual combination

The tool also provides automated, localized supply alerts, according to the company